Inventor
YUYA OGURO
Inventor
JP
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes29%
C07BGeneral methods of organic chemistry4%
PatentTitleYear
12,590,0863-((1H-pyrazol-4-yl)methyl)-6'-(phenyl)-2H-(1,2'-bipyridin)-2-one derivatives and related compounds as GPR139 antagonists for use in a method of treatment of e.g. depression202611,952,344Heterocyclic compound and use thereof202411,834,409Heterocyclic NMDA antagonists202311,827,601Heterocyclic NMDA antagonists202311,746,109Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrate202311,713,311Heterocyclic compound202311,702,419Heterocyclic compound and use thereof202311,230,541Heterocyclic compound2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to TAKEDA PHARMACEUTICALS CO (8)· patent assignee history
2022–2026Based in JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TAKEDA PHARMACEUTICALS CO | 8 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| JP | 8 | 2022–2026 |